Epidemiology of NSAID induced gastrointestinal complications

Journal of Rheumatology

Volumn 26, Issue SUPPL. 56, 1999, Pages 18-24

  Singh, Gurkirpal ^a,b,c   Triadafilopoulos, George ^a,d,e  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ARAMIS Post Marketing Surveillance Program   (United States)

^c STANFORD UNIVERSITY   (United States)

^d Department of of Medicine ^*

^e VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Adverse events; Arthritis; Gastrointestinal; Nonsteroidal antiinflammatory drugs

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTHRITIS; ARTICLE; DOSE RESPONSE; DRUG CHOICE; DRUG SAFETY; GASTROINTESTINAL TOXICITY; HUMAN; PRIORITY JOURNAL;

ANTACIDS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; GASTROINTESTINAL DISEASES; HISTAMINE H1 ANTAGONISTS; HUMANS; PREVALENCE; RISK FACTORS;

EID: 0032931328     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Fries JF, McShane DJ. ARAMIS (The American Rheumatism Association Medical Information System): a prototypical national chronic-disease data bank. West J Med 1986;145:798-804.
2. Singh G, Fries JF, Spitz PW, Williams CA, Bloch DA. Toxic effects of azathioprine in rheumatoid arthritis: a national post-marketing perspective. Arthritis Rheum 1989:32:837-41.
3. Singh G, Fries JF, Williams CA, Zatarain E, Spitz P, Bloch DA. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis. J Rheumatol 1991;18:188-94.
4. Singh G, Ramey DR, Morfeld D, Shi H, Hatoum H, Fries JF. Gastrointestinal tract complications of non-steroidal antiinflammatory drug treatment in rheumatoid arthritis - A prospective observational cohort study. Arch Intern Med 1996; 156:1530-6.
5. Fries JF, Spitz PW, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
6. Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: The Health Assessment Questionnaire, disability and pain scales. J Rheumatol 1982;9:789-93.
7. Ramey DR, Singh GS, Fries JF. The Health Assessment Questionnaire 1995: status and review. In: Spilker B, editor. Pharmacoeconomics and quality of life in clinical trials. 2nd ed. Philadelphia: Lippincott-Raven; 1996:227-37.
8. Ehsanullah RS, Page MC, Tildesley G, Wood JR. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. BMJ 1988;297:1017-21.
9. Graham DY, Smith JL. Gastroduodenal complications of chronic NSAID therapy. Am J Gastroenterol 1988;83:1081-4.
10. Singh G, Ramey DR, Terry R, Triadafilopoulus G. NSAID-related effects on the GI tract: an ever widening spectrum [abstract]. Arthritis Rheum 1997;40 Suppl:S93.
11. Hardin JG, Longenecker GL. Handbook of drug therapy in rheumatic disease: pharmacology and clinical aspects. Boston: Little, Brown, 1992.
12. Goldenberg DL, Cohen AS. Drugs in the rheumatic diseases. New York: Grune and Stratton, 1986.
13. Buchanan WW, Brooks PM. Prediction of organ system toxicity with anti-rheumatic drug therapy. In: Bellamy N, ed. Prognosis in the rheumatic diseases. Boston: Kluwer Academic, 1991:403-50.
14. Singh, G. Recent considerations in non-steroidal anti-inflammatory drug gastropathy. Am J Med 1998;105:31S-8S.
15. Singh G, Ramey DR. NSAID induced gastrointestinal complications: the ARAMIS perspective. J Rheumatol 1998;25 Suppl 51:17-20.
16. Armstrong CP, Blower AL. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulcerations. Gut 1987:28:527-32.
17. National Center for Health Statistics, 1998.
18. Brooks PM, Day RO. Nonsteroidal antiinflammatory drugs -differences and similarities. N Engl J Med 1991;324:1716-25.
19. Bjorkman DJ. Nonsteroidal anti-inflammatory drug-induced gastrointestinal injury. Am J Med 1996;(suppl 1A)101:25S-32S.
20. Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol 1995;90:206-10.
21. Greene JM, Winickoff RN. Cost-conscious prescribing of nonsteroidal anti-inflammatory drugs for adults with arthritis. A review and suggestions. Arch Intern Med 1992;152:1995-2002.
22. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal antiinflammatory drugs. A meta-analysis. Ann Intern Med 1991; 115:787-96.